Some previous studies have suggested that the quantification of HDL particles containing ApoA-I without ApoA-II (LpA-I) could provide additional information in predicting coronary artery disease in the general population, although not all trials have supported this hypothesis [24]. This evidence concerns the gene APOA2 and coronary artery disorder.